Prevalence of Obstructive Sleep Apnea in Acromegaly
Approximately 75-80% of patients with acromegaly develop obstructive sleep apnea (OSA), making it one of the most common complications of this endocrine disorder. This high prevalence highlights the critical importance of screening all acromegaly patients for OSA at diagnosis.
Epidemiological Data on OSA in Acromegaly
- The most recent evidence indicates that OSA affects 76.67% of newly diagnosed acromegaly patients, with moderate to severe OSA affecting 46% of these individuals 1
- Another recent prospective study found a 74.1% prevalence of OSA in treatment-naïve acromegaly patients 2
- A retrospective analysis of acromegaly patients who underwent polysomnography found that 78.1% had OSA (defined as AHI>5), with most (62.5%) having moderate-severe disease 3
Pathophysiological Mechanisms
- OSA in acromegaly results primarily from craniofacial abnormalities and soft tissue overgrowth due to excess growth hormone 1, 4
- Key anatomical changes contributing to OSA in acromegaly include:
Gender Differences
- Women with acromegaly develop OSA at twice the rate of men, contrary to the general population where OSA is more common in males 1
- Despite this difference in prevalence, the polysomnographic features and OSA severity are similar between genders in acromegaly patients 3
Risk Factors for OSA in Acromegaly
- Age is a significant factor, with older acromegaly patients having higher risk of OSA (p=0.007) 3
- A positive correlation exists between age and Apnea-Hypopnea Index (AHI) in acromegaly patients (r:0.426, p:0.015) 3
- Interestingly, body mass index (BMI) does not appear to be a significant differentiator between acromegaly patients with and without OSA, unlike in the general population 3
Treatment Impact on OSA
- Treatment of acromegaly significantly improves OSA in most patients 2
- After 2.5 years of acromegaly treatment, 68.8% of patients with OSA at baseline experienced resolution of their sleep apnea 2
- The greatest improvement in sleep parameters occurs during the first year of acromegaly treatment 2
- Improvements in respiratory disturbance index (RDI), oxygen desaturation index (ODI), lowest oxygen saturation (LSaO2), and Epworth Sleepiness Scale (ESS) correlate with normalization of insulin-like growth factor 1 (IGF-1) levels 2
Clinical Implications
- Given the extremely high prevalence of OSA in acromegaly (75-80% vs. approximately 5% in the general population), polysomnography should be performed in all newly diagnosed acromegaly patients 1, 3
- Middle-aged acromegaly patients should be evaluated for OSA even without obvious obesity 3
- Repeat polysomnography should be considered during acromegaly treatment to assess for improvement in OSA 2